Schnieders Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.98M Buy
27,550
+1,829
+7% +$626K 1.31% 16
2026
Q1
$9.05M Sell
25,721
-15
-0.1% -$5.35K 1.44% 17
2025
Q4
$8.42M Sell
25,736
-73
-0.3% -$23.2K 1.31% 18
2025
Q3
$7.28M Sell
25,809
-50
-0.2% -$14.5K 1.3% 20
2025
Q2
$7.22M Buy
25,859
+5,853
+29% +$1.66M 1.27% 20
2025
Q1
$6.23M Sell
20,006
-1,891
-9% -$558K 1.33% 22
2024
Q4
$5.71M Sell
21,897
-185
-0.8% -$54.9K 1.13% 23
2024
Q3
$7.12M Sell
22,082
-499
-2% -$163K 1.36% 19
2024
Q2
$7.06M Sell
22,581
-567
-2% -$167K 1.42% 20
2024
Q1
$6.58M Buy
23,148
+80
+0.3% +$23.4K 1.36% 21
2023
Q4
$6.64M Sell
23,068
-1,745
-7% -$475K 1.46% 17
2023
Q3
$6.67M Sell
24,813
-126
-0.5% -$31.4K 1.49% 20
2023
Q2
$5.54M Buy
24,939
+103
+0.4% +$23.9K 1.16% 24
2023
Q1
$6M Buy
24,836
+391
+2% +$96K 1.35% 23
2022
Q4
$6.42M Buy
24,445
+250
+1% +$67K 1.47% 20
2022
Q3
$5.45M Buy
24,195
+2,225
+10% +$539K 1.44% 19
2022
Q2
$5.34M Sell
21,970
-765
-3% -$187K 1.59% 17
2022
Q1
$5.5M Sell
22,735
-14
-0.1% -$3.22K 1.31% 21
2021
Q4
$5.12M Buy
22,749
+1,932
+9% +$408K 1.2% 21
2021
Q3
$4.43M Buy
20,817
+180
+0.9% +$41.4K 1.19% 23
2021
Q2
$5.03M Buy
20,637
+1,381
+7% +$340K 1.37% 19
2021
Q1
$4.79M Buy
19,256
+320
+2% +$76.4K 1.44% 21
2020
Q4
$4.35M Buy
18,936
+200
+1% +$46.1K 1.43% 22
2020
Q3
$4.76M Sell
18,736
-135
-0.7% -$33.4K 1.79% 16
2020
Q2
$4.45M Sell
18,871
-303
-2% -$69.1K 1.77% 18
2020
Q1
$3.89M Sell
19,174
-725
-4% -$158K 1.87% 15
2019
Q4
$4.8M Buy
19,899
+550
+3% +$121K 1.74% 16
2019
Q3
$3.74M Sell
19,349
-2,333
-11% -$448K 1.51% 19
2019
Q2
$4M Buy
21,682
+1,638
+8% +$293K 1.57% 17
2019
Q1
$3.81M Sell
20,044
-600
-3% -$115K 1.63% 18
2018
Q4
$4.02M Buy
20,644
+25
+0.1% +$4.88K 1.97% 13
2018
Q3
$4.27M Sell
20,619
-500
-2% -$98.5K 1.75% 16
2018
Q2
$3.9M Sell
21,119
-427
-2% -$75.5K 1.65% 17
2018
Q1
$3.67M Buy
21,546
+905
+4% +$166K 1.58% 17
2017
Q4
$3.59M Buy
20,641
+200
+1% +$35.4K 1.48% 21
2017
Q3
$3.81M Buy
20,441
+260
+1% +$46.1K 1.66% 17
2017
Q2
$3.48M Buy
20,181
+446
+2% +$72.5K 1.62% 16
2017
Q1
$3.24M Buy
19,735
+760
+4% +$126K 1.55% 17
2016
Q4
$2.77M Sell
18,975
-150
-0.8% -$22.6K 1.43% 23
2016
Q3
$3.19M Buy
19,125
+725
+4% +$123K 1.79% 12
2016
Q2
$2.8M Buy
18,400
+350
+2% +$54.4K 1.56% 16
2016
Q1
$2.71M Hold
18,050
1.6% 18
2015
Q4
$2.93M Buy
18,050
+775
+4% +$122K 1.8% 15
2015
Q3
$2.39M Buy
17,275
+890
+5% +$140K 1.65% 17
2015
Q2
$2.52M Buy
16,385
+1,270
+8% +$203K 1.48% 21
2015
Q1
$2.42M Buy
15,115
+2,410
+19% +$380K 1.46% 19
2014
Q4
$2.02M Buy
12,705
+1,240
+11% +$193K 1.34% 23
2014
Q3
$1.61M Buy
11,465
+175
+2% +$22.8K 1.19% 24
2014
Q2
$1.34M Buy
11,290
+2,025
+22% +$234K 0.94% 33
2014
Q1
$1.14M Buy
9,265
+1,470
+19% +$178K 1.06% 32
2013
Q4
$889K Buy
+7,795
New +$887K 0.87% 39

Other funds holding AMGN

Schnieders Capital Management's AMGN Position: Q2 2026 in Review

Schnieders Capital Management increased its Amgen (AMGN) stake by 7.1% in Q2 2026, buying an estimated $626K and bringing the position to 27,550 shares worth $9.98M. The position accounts for 1.31% of the portfolio, ranked #16.

Schnieders Capital Management first reported a position in AMGN in Q4 2013 and has held it in 51 quarters since. 1,223 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Schnieders Capital Management held 27,550 shares of Amgen worth $9.98M as of Q2 2026.
  • Schnieders Capital Management bought 1,829 Amgen shares in Q2 2026, an estimated $626K.
  • Amgen made up 1.31% of Schnieders Capital Management's portfolio in Q2 2026, its #16 holding.
  • Schnieders Capital Management first reported a position in Amgen in Q4 2013 and has held it in 51 quarters since.
  • 1,223 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Schnieders Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.